Combination of clinical characteristics and transrectal ultrasound-guided biopsy to predict lobes without significant cancer: application in patient selection for hemiablative focal therapy

Djulbegovic, 2010, Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials, BMJ, 341, c4543, 10.1136/bmj.c4543 Baade, 2013, Epidemiology of prostate cancer in the Asia-Pacific region, Prostate Int, 1, 47, 10.12954/PI.12014 Sanda, 2008, Quality of life and satisfaction with outcome among prostate-cancer survivors, N Engl J Med, 358, 1250, 10.1056/NEJMoa074311 Wilt, 2008, Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer, Ann Intern Med, 148, 435, 10.7326/0003-4819-148-6-200803180-00209 Latini, 2007, The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance, J Urol, 178, 826, 10.1016/j.juro.2007.05.039 Bahn, 2012, Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years, Eur Urol, 62, 55, 10.1016/j.eururo.2012.03.006 Ahmed, 2007, Will focal therapy become a standard of care for men with localized prostate cancer?, Nat Clin Pract Oncol, 4, 632, 10.1038/ncponc0959 Ahmed, 2012, Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study, Lancet Oncol, 13, 622, 10.1016/S1470-2045(12)70121-3 Tareen, 2009, Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort, Urology, 73, 351, 10.1016/j.urology.2008.08.504 Wise, 2002, Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens, Urology, 60, 264, 10.1016/S0090-4295(02)01728-4 Noguchi, 2003, Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers, J Urol, 170, 459, 10.1097/01.ju.0000070928.49986.04 Bott, 2010, The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer, BJU Int, 106, 1607, 10.1111/j.1464-410X.2010.09436.x Karavitakis, 2011, Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy, Prostate Cancer Prostatic Dis, 14, 46, 10.1038/pcan.2010.16 McNeal, 1988, Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread, Am J Surg Pathol, 12, 897, 10.1097/00000478-198812000-00001 Renshaw, 1997, Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice, Am J Clin Pathol, 107, 704, 10.1093/ajcp/107.6.704 Porten, 2010, The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease, BJU Int, 105, 472, 10.1111/j.1464-410X.2009.08774.x Epstein, 1994, Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer, JAMA, 271, 368, 10.1001/jama.1994.03510290050036 Tsivian, 2010, Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended, BJU Int, 105, 1089, 10.1111/j.1464-410X.2009.08904.x Polascik, 2009, Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy, Cancer, 115, 2104, 10.1002/cncr.24258 Park, 2007, Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens, Int J Urol, 14, 704, 10.1111/j.1442-2042.2007.01795.x Allan, 2003, Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density, J Urol, 170, 370, 10.1097/01.ju.0000074747.72993.cb Thong, 2008, A single microfocus (5% or less) of Gleason 6 prostate cancer at biopsy: can we predict adverse pathological outcomes?, J Urol, 180, 2436, 10.1016/j.juro.2008.08.027 D'Amico, 2000, Pathologic findings and prostate specific antigen outcome after radical prostatectomy for patients diagnosed on the basis of a single microscopic focus of prostate carcinoma with a gleason score </= 7, Cancer, 89, 1810, 10.1002/1097-0142(20001015)89:8<1810::AID-CNCR22>3.0.CO;2-9 Boccon-Gibod, 2005, Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features, Eur Urol, 48, 895, 10.1016/j.eururo.2005.04.033 Giannarini, 2012, Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature, Eur Urol, 61, 326, 10.1016/j.eururo.2011.09.019 Schiebler, 1989, Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings, Radiology, 172, 131, 10.1148/radiology.172.1.2472644 White, 1995, Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images, Radiology, 195, 385, 10.1148/radiology.195.2.7724756 Matsuoka, 2014, Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy, Eur Urol, 65, 186, 10.1016/j.eururo.2012.10.010